Company intelligence / Profile preview

De.mem

Melbourne, Victoria, Australiademem-capic.com.au ↗

Ownership: Private
Development stage: Commercial

Overview

De.mem has achieved record revenue growth in recent years. In 2024 revenues increased by approximately 6% year-over-year to $24.9 million AUD with strong recurring revenue from long-term service contracts. The company commercializes proprietary hollow-fibre membranes including graphene oxide-enhanced products now certified for potable use in the US market. It also launched new small-scale filtration systems targeting domestic and small industrial applications.

Industry: Non-Drug Biotech

Partnerships

Aromatec Pte LtdPurafy Clean Technologies/Grafoid Inc.

Beyond the preview

Go deeper on De.mem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on De.mem.

Explore the full profile